Fawcett John Randall 4
4 · Prothena Corp plc · Filed Jan 31, 2013
Insider Transaction Report
Form 4
Fawcett John Randall
Controller
Transactions
- Award
Stock Option (right to buy)
2013-01-29+36,000→ 36,000 totalExercise: $6.41Exp: 2023-01-29→ Ordinary Shares (36,000 underlying)
Holdings
- 335
Ordinary Shares, par value $0.01 per share
Footnotes (3)
- [F1]Represents one less ordinary share than the amount previously reported on Reporting Person's Form 3, Initial Statement of Beneficial Ownership, due to a rounding error in calculating the number of ordinary shares received by Reporting Person in the distribution of Issuer's ordinary shares in the spin-off of the Issuer from Elan Pharmaceuticals, Inc., which was completed on December 20, 2012.
- [F2]Exercise price is equal to the average per share closing price of the Issuer's ordinary shares for the first 25 trading days commencing on December 21, 2012.
- [F3]The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on January 29, 2014 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.